Journal of Shanghai Jiao Tong University (Medical Science) >

2022 , Vol. 42 >Issue 9: 1197 - 1207

DOI: https://doi.org/10.3969/j.issn.1674-8115.2022.09.006

Innovative research team achievement column

Transcriptomic analysis of metabolic characteristics of the immune cells in systemic lupus erythematosus patients

  • Xiaxia HAN ,
  • Yang JIANG ,
  • Shuangshuang GU ,
  • Dai DAI ,
  • Nan SHEN
Expand
  • Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Institute of Rheumatology, Shanghai 200127, China
SHEN Nan, E-mail: nanshensibs@gmail.com.

Received date: 2022-03-28

  Accepted date: 2022-06-16

  Online published: 2022-09-28

Supported by

National Natural Science Foundation of China(31630021);Innovative Research Team of High Level Local Universities in Shanghai(SSMU-ZDCX20180100)

Fold

Abstract

Objective ·To study the metabolic pathway activity level of the immune cell subsets in the patients with systemic lupus erythematosus (SLE) by bioinformatics analysis. Methods ·The matrix expression data of PBMCs collected from SLE patients and healthy controls were downloaded from Gene Expression Omnibus (GEO) Datasets, as well as the transcriptome data of T cell and B cell subsets from SLE patients and healthy controls. The differentially-expressed genes (DEGs) were identified in the standardized sequence data. Pathway enrichment analysis of DEGs was performed by online Enrichr tools, and the common up-regulated pathways were determined by comparative analysis. Gene set enrichment analysis (GSEA) was used to identify pathways that were enriched in the experiment processed with the whole gene expression matrix. RNA-seq data from PBMCs samples of SLE patients and healthy controls were used to characterize the immune cell composition. The targeted pathway was annotated with gene expression. Assay for transposase-accessible chromatin using sequencing (ATAC-seq) technique was performed to detect the chromatin accessibility of glycolysis-related genes in SLE patients and healthy controls. Results ·① Venn diagram depicted 139 common upregulated pathways in GSE169080, GSE144390 and GSE139350 data sets, and GSEA results showed that multiple classical metabolic pathways, including glycolysis, oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO), were up-regulated in SLE patients. ② Immune cell composition analysis of PBMCs showed that the proportions of T cells, B cells and NK cells were higher in SLE patients, and the expression of genes encoding multiple enzymes of metabolic pathway in T cells and B cells were higher than those in healthy controls. ③ Compared to healthy controls, the intensity of ATAC-seq signal was significantly enhanced at transcriptional regulatory sites of SLC2A3, PKM and LDHA in peripheral B cells from SLE patients. ④ GSEA results and visualization analysis of metabolic pathways of SLE B cell subsets showed that the memory B cells and plasmablasts displayed a higher metabolic state than na?ve B cells. Conclusion ·Multiple metabolic pathways are altered in SLE patients and the metabolic level of effector B cells is higher than na?ve B cells in SLE patients.

Key words： systemic lupus erythematous (SLE); metabolic pathway; Gene Expression Omnibus (GEO); bioinformatics; B cell

Cite this article

Xiaxia HAN , Yang JIANG , Shuangshuang GU , Dai DAI , Nan SHEN . Transcriptomic analysis of metabolic characteristics of the immune cells in systemic lupus erythematosus patients[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022 , 42(9) : 1197 -1207 . DOI: 10.3969/j.issn.1674-8115.2022.09.006

References

1 D?RNER T, FURIE R. Novel paradigms in systemic lupus erythematosus[J]. Lancet, 2019, 393(10188): 2344-2358.
2 HE J Q, CHAN T L, HONG X P, et al. Microbiome and metabolome analyses reveal the disruption of lipid metabolism in systemic lupus erythematosus[J]. Front Immunol, 2020, 11: 1703.
3 ZHANG L S, QING P Y, YANG H, et al. Gut microbiome and metabolites in systemic lupus erythematosus: link, mechanisms and intervention[J]. Front Immunol, 2021, 12: 686501.
4 CHOI S C, BROWN J, GONG M H, et al. Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice[J]. Sci Transl Med, 2020, 12(551): eaax2220.
5 YIN Y M, CHOI S C, XU Z W, et al. Glucose oxidation is critical for CD4+ T cell activation in a mouse model of systemic lupus erythematosus[J]. J Immunol, 2016, 196(1): 80-90.
6 YIN Y M, CHOI S C, XU Z W, et al. Normalization of CD4+ T cell metabolism reverses lupus[J]. Sci Transl Med, 2015, 7(274): 274ra18.
7 O'NEILL L A J, KISHTON R J, RATHMELL J. A guide to immunometabolism for immunologists[J]. Nat Rev Immunol, 2016, 16(9): 553-565.
8 WU T F, QIN X M, KUREPA Z, et al. Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus[J]. J Clin Invest, 2007, 117(8): 2186-2196.
9 SARAVIA J, RAYNOR J L, CHAPMAN N M, et al. Signaling networks in immunometabolism[J]. Cell Res, 2020, 30(4): 328-342.
10 MAKOWSKI L, CHAIB M, RATHMELL J C. Immunometabolism: From basic mechanisms to translation[J]. Immunol Rev, 2020, 295(1): 5-14.
11 HOU G J, HARLEY I T W, LU X M, et al. SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression[J]. Nat Commun, 2021, 12(1): 135.
12 CHEN E Y, TAN C M, KOU Y, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool[J]. BMC Bioinformatics, 2013, 14: 128.
13 STURM G, FINOTELLO F, PETITPREZ F, et al. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology[J]. Bioinformatics, 2019, 35(14): i436-i445.
14 SHLOMCHIK M J, CRAFT J E, MAMULA M J. From T to B and back again: positive feedback in systemic autoimmune disease[J]. Nat Rev Immunol, 2001, 1(2): 147-153.
15 CORCORAN L M, NUTT S L. Long-lived plasma cells have a sweet tooth[J]. Immunity, 2016, 45(1): 3-5.
16 ZHOU X, MOTTA F, SELMI C, et al. Antibody glycosylation in autoimmune diseases[J]. Autoimmun Rev, 2021, 20(5): 102804.
17 REILY C, STEWART T J, RENFROW M B, et al. Glycosylation in health and disease[J]. Nat Rev Nephrol, 2019, 15(6): 346-366.
18 CORRADO M, PEARCE E L. Targeting memory T cell metabolism to improve immunity[J]. J Clin Invest, 2022, 132(1): e148546.
19 SUN L, ZHANG H, GAO P. Metabolic reprogramming and epigenetic modifications on the path to cancer[J]. Protein Cell, 2021: 2021May29.
20 ZHENG Y, WU C, YANG J M, et al. Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer[J]. Signal Transduct Target Ther, 2020, 5(1): 53.
21 QIU R, YU X, WANG L, et al. Inhibition of glycolysis in pathogenic TH17 cells through targeting a miR-21-Peli1-c-rel pathway prevents autoimmunity[J]. J Immunol, 2020, 204(12): 3160-3170.
22 HUANG N, PERL A. Metabolism as a target for modulation in autoimmune diseases[J]. Trends Immunol, 2018, 39(7): 562-576.
23 ERIKSSON P, WALLIN P, SJ?WALL C. Clinical experience of sirolimus regarding efficacy and safety in systemic lupus erythematosus[J]. Front Pharmacol, 2019, 10: 82.
24 SUN F F, GENG S K, WANG H T, et al. Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials[J]. Lupus Sci Med, 2020, 7(1): e000429.
Options
Outlines

/

〈 〉